Evidence map›Paper›PMID 28582565›Full record

ArticleBioinformatics (Oxford, England)2017

ISAMBARD: an open-source computational environment for biomolecular analysis, modelling and design.

Christopher W Wood, Jack W Heal, Andrew R Thomson, Gail J Bartlett, Amaurys Á Ibarra, R Leo Brady, Richard B Sessions, Derek N Woolfson

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Exploring the Blueprint of Life: The Innovation in Antibody and Protein Design.Combinatorial chemistry & high throughput screening · 2026
    Article
  5. Review
  6. Chemical science · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Computational Protein Design - Where it goes?Current medicinal chemistry · 2024
    Review
  14. An expandable, modular de novo protein platform for precision redox engineering.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Coiled coils 9-to-5: rationalChemical science · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christopher W WoodSchool of Chemistry, University of Bristol, Bristol BS8 1TS, UK.
Jack W HealSchool of Chemistry, University of Bristol, Bristol BS8?1TS, UK.
Andrew R ThomsonSchool of Chemistry, University of Bristol, Bristol BS8 1TS, UK.
Gail J BartlettSchool of Chemistry, University of Bristol, Bristol BS8?1TS, UK.
Amaurys Á IbarraSchool of Biochemistry, University of Bristol, Bristol BS8?1TD, UK.
R Leo BradySchool of Biochemistry, University of Bristol, Bristol BS8?1TD, UK.
Richard B SessionsSchool of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.
Derek N WoolfsonSchool of Chemistry, University of Bristol, Bristol BS8 1TS, UK.

Funding

Biotechnology and Biological Sciences Research Council BB/L01386X/1European Research Council 340764
6 · The paper itself

Abstract

motivationThe rational design of biomolecules is becoming a reality. However, further computational tools are needed to facilitate and accelerate this, and to make it accessible to more users.

resultsHere we introduce ISAMBARD, a tool for structural analysis, model building and rational design of biomolecules. ISAMBARD is open-source, modular, computationally scalable and intuitive to use. These features allow non-experts to explore biomolecular design in silico. ISAMBARD addresses a standing issue in protein design, namely, how to introduce backbone variability in a controlled manner. This is achieved through the generalization of tools for parametric modelling, describing the overall shape of proteins geometrically, and without input from experimentally determined structures. This will allow backbone conformations for entire folds and assemblies not observed in nature to be generated de novo, that is, to access the 'dark matter of protein-fold space'. We anticipate that ISAMBARD will find broad applications in biomolecular design, biotechnology and synthetic biology. AVAILABILITY AND IMPLEMENTATION: A current stable build can be downloaded from the python package index (https://pypi.python.org/pypi/isambard/) with development builds available on GitHub (https://github.com/woolfson-group/) along with documentation, tutorial material and all the scripts used to generate the data described in this paper. CONTACT: d.n.woolfson@bristol.ac.uk or chris.wood@bristol.ac.uk. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Protein ConformationSoftwareComputer SimulationModels, MolecularProtein FoldingProteinsProteins

Identifiers

PMID28582565
PMCPMC5870769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.